本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kiniksa Pharmaceuticals Ltd.

78.79
-0.4550-0.57%
成交量:26.55万
成交额:2,104.19万
市值:61.47亿
市盈率:79.58
高:80.00
开:79.34
低:78.66
收:79.24
52周最高:82.94
52周最低:35.20
股本:7,802.40万
流通股本:3,994.15万
量比:1.00
换手率:0.66%
股息:- -
股息率:- -
每股收益(TTM):0.9900
每股收益(LYR):0.7500
净资产收益率:14.04%
总资产收益率:8.05%
市净率:9.40
市盈率(LYR):105.05

数据加载中...

2025/06/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/05

重要事件披露

Form 8-K - Current report
2025/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/03

重要事件披露

Form 8-K - Current report
2025/05/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/29

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]